173.809 articles found

Angiotensin II-induced hypertension does not exacerbate α-SYNUCLEIN pathology in a mouse model of Parkinson’s disease

Silva-Llanes I, Flores-Téllez D, Arrua W, El Jouhari N, Oliver E, Martínez A, Briones A, Lastres-Becker I.

Frontiers in immunology · 2026-10-10

Tau protein in Parkinson’s disease: advances in phosphoproteomics and molecular dynamics simulations

Ledesma-Aparicio J, Caro-Gómez L, Padilla-Godínez F, Hernández-González O, Soto-Rojas L, Reyes-Grajeda J, Arias-Carrión O, Palomero-Rivero M, Bertrand B, Munoz-Garay C, Guerra-Crespo M.

Frontiers in aging neuroscience · 2026-10-10

Ketogenic Diet and Neurological Health: A Narrative Review with Natural Language Processing-Assisted Thematic Mapping Using BERTopic.

Jin B, Chen Z, Xie R, Liu Y.

Neuropsychiatr Dis Treat · 2026-10-10

DOI: 10.2147/ndt.s627639PMID: 42877272

Cerebellar Network Organization in Parkinson's Disease: Functional Connectivity across Motor and Cognitive Circuits.

Lin CR, Magalhães TNC, Yonce SS, Rampalli I, Mahabir R, Bernard JA, and the Parkinson's Precision Medicine Initiative.

Mov Disord · 2026-10-10

DOI: 10.1002/mds.70564PMID: 42857890

Bilateral multi-condition surface electromyographic characterization of tremor in Parkinson's disease and essential tremor.

Ekinci AS, Gündoğan S, Tanrıverdi Z, Arıcı Ş, Seçil Y.

Acta Neurol Belg · 2026-10-10

DOI: 10.1007/s13760-026-03209-3PMID: 42858207

Three-dimensional Motion Capture Discriminates Extremely Mild Cerebellar Ataxia from Parkinsonism in the Upper Limbs.

Ueda N, Abe K, Kobayashi E, Hayashi N, Higashiyama Y, Miyaji Y, Kitazawa Y, Takeuchi H, Kimura K, Kishida H, Doi H, Tanaka F.

Cerebellum · 2026-10-10

DOI: 10.1007/s12311-026-02098-9PMID: 42858219

Exploring the risk of melanoma in people with Parkinson's disease: a systematic review and meta-analysis.

Galappaththie U, Weber A, Hall L, Heal C.

Dermatology · 2026-10-10

DOI: 10.1159/drm/ackag025PMID: 42858286

Transcranial magneto-acoustic stimulation modulates M1-PPN spike-LFP coupling and improves motor dysfunction in parkinsonian rats.

Zhang S, Wang Y, Xu Y, Lu X, Zhai S, Yue K, Zhang X, Liu P, Xu G.

Exp Neurol · 2026-10-10

DOI: 10.1016/j.expneurol.2026.116059PMID: 42858799

MIND diet adherence and Parkinson's disease risk, progression, and age at onset: A systematic review.

Pitton Rissardo J, McGarry A, Fornari Caprara AL, Walker IM.

Clin Nutr ESPEN · 2026-10-10

DOI: 10.1016/j.clnesp.2026.105193PMID: 42858790

A GLP-1/apelin dual receptor agonist shows neuroprotective effects in the MPTP mouse model of Parkinson's disease.

Xu A, Wei Y, Liu E, Tong W, Lu A, Zhang F, Flatt P, Gault V, Irwin N, Hölscher C, Zhang Z.

Biochem Pharmacol · 2026-10-10

DOI: 10.1016/j.bcp.2026.118534PMID: 42858820

Glyceryl tribenzoate, a flavoring agent, stimulates hippocampal plasticity and protects memory via PPARα.

Patel DR, Rangasamy SB, Gorai S, Paidi RK, Pahan K.

Neurochem Int · 2026-10-10

DOI: 10.1016/j.neuint.2026.106270PMID: 42858944

Corrigendum to "Tianma Gouteng granules decreases the susceptibility of Parkinson's disease by inhibiting ALOX15-mediated lipid peroxidation" [J. Ethnopharmacol. 256, (2020), 112824].

Jiang YN, Guo YZ, Lu DH, Pan MH, Liu HZ, Jiao GL, Bi W, Kurihara H, Li YF, Duan WJ, He RR, Yao XS.

J Ethnopharmacol · 2026-10-10

DOI: 10.1016/j.jep.2026.122456PMID: 42859111